Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer

By Laufer M.   Sinibaldi V.J.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 745-745

Elsevier

Access to resources Recommend Favorite

Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors

By Robinson David   Aus Gunnar   Bak Julia   Gorecki Tomasz   Herder Anders   Rosell Johan   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 2, 2007-01 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite

Approaches to prostate cancer by managed care organizations

By Bennett C.L.   Buchner D.A.   Ullman M.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

Predictive factors of biochemical progression in prostate cancer patients treated with intermittent androgen suppression

By de la Taille A.   Zerbib M.   Conquy S.   Amsellem-Ouazana D.   Thiounn N.   Flam T.   Saighi D.   Debre B.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 135-135

Elsevier

Access to resources Recommend Favorite

Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer

By Berge Viktor  

Scandinavian Journal of Urology and Nephrology, Vol. 46, Iss. 1, 2012-02 ,pp. : 8-13

Informa Healthcare

Access to resources Recommend Favorite